BD MAX Enteric Bacterial Panel, BD MAX Extended Enteric Bacterial Panel— 510(k) K214122

Substantially Equivalent

Becton, Dickinson and Company

FDA 510(k) clearance K214122 for BD MAX Enteric Bacterial Panel, BD MAX Extended Enteric Bacterial Panel, Substantially Equivalent on 2022-07-28. Applicant: Becton, Dickinson and Company. Device class: 2.

Clearance details

Applicant
Becton, Dickinson and Company
Product code
Code PCI
Device class
Class 2
Regulation
21 CFR 866.3990
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Sparks, MD, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code PCI

view all

More clearances from Becton, Dickinson and Company

view all

Data sourced from openFDA. This site is unofficial and independent of the FDA.